Generic Velcade in 2017 means BYE BYE KRAPOLIS!!!

FUCK YEAH! I'm going to be out of Amgen soon and now Onyx reps are under the gun!

Bob Bradway better buy some more cuz that revenue is going bye bye!

Takeda takes unexpected blow as blockbuster Velcade patent ruled invalid
U.S. court shaves 5 years off Veclade patent protection, generics could hit in 2017

With approvals in the U.S and Europe expected soon, it looked like Takeda would have time to get its new multiple myeloma treatment into the market before patents fell off of blockbuster Velcade in 2022. But CEOChristophe Weber may need to plot a new strategy after a federal judge overturned a key patent, putting the Japanese drugmaker's drug vulnerable to generics 5 years early.

 

In case you haven't noticed all the Kyprolis reps are leaving or have left. Amgen sucks!

 

Did someone yell abandon ship? No bonus, no car, no phone = abandon ship!!

 

Blood bath this week.

 

Ludwig is pissed all of the Onyx reps are leaving during a label expansion launch!

 

I will continue to serve patients under Ludwigs great leadership

 

You're a drug rep...the patients will be just fine without you or JL's 'leadership'.

 

ONYX is JEALOUS of OBU because they are losers!!!!!!!

 

Step away from the bottle supportive care hack...no one in the oncology world is jealous of Amgen and its 'OBU'. You guys are the entry level supportive care reps that no one takes seriously for good reason.

 

When we get your product, we will then infiltrate whatever company you go to and then CRUSH you

 

You loser will never get hired by the places we land...you losers are stuck here with your supportive care experience and terrible reputation in the industry.

Everyone laughs at the Amgen OBU...everyone!

 

The power of Jeff Ludwig, Bob Azelby, Richard Paulson, Rolf Hoffman, Eric Jensen, Sebastien Meyer, Jim Hassard, Mark McClung, and Rhonda Farnum will protect me against Onyx losers like you!

Together your life will be obsolete!

Team Amgen wins baby!

 

Wow you just listed the Mount Rushmore of washed up has beens.

 

Jason Oliger and Josh Neimann would run circles around this group. They actually sold and marketed a true Oncology therapeutic before Onyx. Anyone on your team do that? Nope !